Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 4/20 | 0.33 |
| ▸ | TBXAS1 | P24557 | 3/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.33 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.33 |
| ▸ | PPARG | P37231 | 4/20 | 0.32 |
| ▸ | PPARD | Q03181 | 4/20 | 0.32 |
| ▸ | PPARA | Q07869 | 4/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.32 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6115678 | 0.98 | TBXAS1 (0.36) | LMNASLC22A6TSHRTBXAS1NFKB1 | |
| SCHEMBL18211781 | 0.93 | TSHR (0.40) | LMNASLC22A6TSHRTBXAS1NFKB1 | |
| SCHEMBL22916707 | 0.93 | TSHR (0.40) | LMNASLC22A6TSHRTBXAS1NFKB1 | |
| SCHEMBL18211773 | 0.93 | TSHR (0.40) | LMNASLC22A6TSHRTBXAS1NFKB1 | |
| SCHEMBL18211771 | 0.93 | TSHR (0.40) | LMNASLC22A6TSHRTBXAS1NFKB1 | |
| Bromide SCHEMBL1977150 | 0.92 | TSHR (0.39) | LMNASLC22A6TSHRTBXAS1NFKB1 | |
| SCHEMBL717072 | 0.89 | EGLN3 (0.32) | MEN1KMT2AHSP90AA1SMN1; SMN2KDM4E | |
| Glutarate SCHEMBL29142326 | 0.89 | MEN1 (0.40) | SLC22A6TSHRAKR1B1MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL29008264 | 0.87 | EGLN3 (0.34) | TBXAS1MEN1KMT2AHSP90AA1SMN1; SMN2 | |
| Bromide SCHEMBL571256 | 0.87 | MEN1 (0.33) | MEN1KMT2AHSP90AA1SMN1; SMN2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020230721-A1 | UNDIFFERENTIATION PROMOTER AND CRYOPROTECTIVE AGENT USING APROTONIC DIPOLAR ION | 国立研究開発法人科学技術振興機構 | 2020-11-19 | — | — | WO | disclosed |
| US-20170341067-A1 | Palladium Catalyst System Comprising Zwitterion And/Or Acid-Functionalyzed Ionic Liquid | UNIV DENMARK TECH DTU (DK) | 2017-11-30 | — | — | US | disclosed |
| US-20150094486-A1 | ACTIVE IONIC LIQUID MIXTURES FOR OXIDIZING ALKYLAROMATIC COMPOUNDS | UOP LLC (US) | 2015-04-02 | — | — | US | disclosed |
| US-20130206234-A1 | ELECTROLYTE FOR PHOTOELECTRIC CONVERSION ELEMENT, AND PHOTOELECTRIC CONVERSION ELEMENT AND DYE-SENSITISED SOLAR CELL USING SAME | THE YOKOHAMA RUBBER CO., LTD. (JP) | 2013-08-15 | — | — | US | disclosed |
| EP-1660457-B1 | IONIC LIQUIDS BASED ON IMIDAZOLIUM SALTS INCORPORATING A NITRILE FUNCTIONALITY | ECOLE POLYTECH (CH) | 2011-09-28 | — | — | EP | disclosed |
| US-20110065950-A1 | PALLADIUM CATALYST SYSTEM COMPRISING ZWITTERION AND/OR ACID-FUNCTIONALYZED IONIC LIQUID | TECHNICAL UNIVERSITY OF DENMARK (DK) | 2011-03-17 | — | — | US | disclosed |
| US-20110065950-A1 | PALLADIUM CATALYST SYSTEM COMPRISING ZWITTERION AND/OR ACID-FUNCTIONALYZED IONIC LIQUID | TECHNICAL UNIVERSITY OF DENMARK (DK) | 2011-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110065950-A1 | PALLADIUM CATALYST SYSTEM COMPRISING ZWITTERION AND/OR ACID-FUNCTIONALYZED IONIC LIQUID | PDCD2L, PCCA, PDK2 | LMNA 4076/4885SLC22A6 4141/4885TSHR 4227/4885 |
| US-20170341067-A1 | Palladium Catalyst System Comprising Zwitterion And/Or Acid-Functionalyzed Ionic Liquid | PDCD2L, PCCA, PDK2 | LMNA 4076/4885SLC22A6 4141/4885TSHR 4227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.